Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial.
Saved in:
| Title: | Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial. |
|---|---|
| Authors: | Krausewitz P; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany; Philipp.Krausewitz@ukbonn.de., Essler M; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany., Gaertner FC; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany., Attenberger U; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany., Luetkens JA; Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany., Kristiansen G; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Bernhardt M; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Ohlmann CH; Department of Urology, Johanniter Hospital Bonn, Bonn, Germany; and., Anspach M; Department of Urology, Johanniter Hospital Bonn, Bonn, Germany; and., Schmid M; Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany., Nemeth R; Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany., Schmitz J; Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany., Hauser S; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany., Ellinger J; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany., Ritter M; Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Jan 02; Vol. 67 (1), pp. 60-66. Date of Electronic Publication: 2026 Jan 02. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-5667 |
|---|---|
| DOI: | 10.2967/jnumed.125.271344 |
